Ad hoc-Mitteilungen
• 09.04.21 MICRO SYSTEMAT. B SK-,20 • 09.04.21 Sanofi S.A. • 09.04.21 ROMREAL LTD. • 09.04.21 Datacolor • 09.04.21 Dialog Semiconductor • 09.04.21 asknet Solutions AG • 09.04.21 DEUTSCHE POST WLD.17/25 • 09.04.21 Yara International • 09.04.21 Yara International • 09.04.21 AGRARIUS IHS 20/26 •
  • Startseite
  • Aktien
  • UCB Aktie
  • News
  • aktualisieren
  • Specials: Webinare

    • UCB News

    Werbung
    Weiter aufwärts?
    Zum Produkt
    Long Hebel 7,23
    MA2725
    81,19 € 0,00% +0,00 €
    18:13:18 Uhr L&S RT | Mehr Kurse »
    WKN: 852738
    ISIN: BE0003739530
    US-Symbol: UCBJF
    Typ: Aktie
    Jetzt für 0€ handeln

    UCB News

      
    < Zurück < Zurück
    von 16
    Weiter > Weiter >
    < Zurück < Zurück
    von 16
    Weiter > Weiter >
    26.03.21 - GlobeNewswire
    UCB SA/NV - Convening notice annual shareholders meeting
    *** Unofficial English translation – For convenience purposes only ***
    29.07.20 - PR Newswire
    UCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer's Disease
    UCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer's Disease PR Newswire
    29.07.20 - PR Newswire
    UCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer's Disease
    UCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer's Disease PR Newswire
    27.07.20 - PR Newswire
    UCB Half Year Report 2020
    UCB Half Year Report 2020 UCB's resilient product portfolio drives continued company growth PR Newswire
    27.07.20 - PR Newswire
    UCB Half Year Report 2020
    UCB Half Year Report 2020 PR Newswire
    05.06.20 - PR Newswire
    UCB Acquires Engage Therapeutics: Staccato® Alprazolam - A potential Solution for Acute On-demand Seizure Management for People Living With Epilepsy
    UCB Acquires Engage Therapeutics: Staccato® Alprazolam - A potential Solution for Acute On-demand Seizure Management for People Living With Epilepsy - Underlines UCB's ...
    05.06.20 - PR Newswire
    UCB Acquires Engage Therapeutics: Staccato® Alprazolam - A potential Solution for Acute On-demand Seizure Management for People Living With Epilepsy
    UCB Acquires Engage Therapeutics: Staccato® Alprazolam - A potential Solution for Acute On-demand Seizure Management for People Living With Epilepsy PR Newswire
    01.04.20 - PR Newswire
    ADVANZ PHARMA Corp. Limited Closes Acquisition of the Rights to a Portfolio of Alprostadil Products from UCB S.A. for $83 Million
    ADVANZ PHARMA Corp. Limited Closes Acquisition of the Rights to a Portfolio of Alprostadil Products from UCB S.A. for $83 Million PR Newswire
    27.03.20 - GlobeNewswire
    UCB SA/NV : Convening notice to the general meeting of shareholders
    *** Unofficial English translation – For convenience purposes only ***  UCB SA/NV - Public Limited Liability Company Allée de la Recherche 60, 1070 Brussels Enterprise nr. ...
    06.03.20 - PR Newswire
    ADVANZ PHARMA Corp. Limited Announces Definitive Agreement to Acquire The Rights To A Portfolio Of Alprostadil Products From UCB S.A. For Approximately $84 Million
    ADVANZ PHARMA Corp. Limited Announces Definitive Agreement to Acquire The Rights To A Portfolio Of Alprostadil Products From UCB S.A. For Approximately $84 Million PR ...
    12.12.19 - PR Newswire
    UCB: Osteoporose Patientinnen sind der Meinung, die Gesundheits-behörden würden ihre Krankheit vernachlässigen und zurückstufen
    UCB: Osteoporose Patientinnen sind der Meinung, die Gesundheits-​behörden würden ihre Krankheit vernachlässigen und zurückstufen PR Newswire
    12.12.19 - PR Newswire
    UCB: Osteoporosis Patients Believe Their Condition is Neglected and Deprioritised by Healthcare Authorities
    UCB: Osteoporosis Patients Believe Their Condition is Neglected and Deprioritised by Healthcare Authorities PR Newswire
    09.12.19 - PR Newswire
    UCB Presents Final Results from Phase II Study of Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) at 2019 ASH Annual Meeting
    UCB Presents Final Results from Phase II Study of Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) at 2019 ASH Annual Meeting - Phase II data demonstrate that ...
    09.12.19 - PR Newswire
    UCB Presents Final Results from Phase II Study of Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) at 2019 ASH Annual Meeting
    UCB Presents Final Results from Phase II Study of Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) at 2019 ASH Annual Meeting PR Newswire
    26.07.19 - PR Newswire
    Halbjahresbericht 2019: Starkes Ergebnis ermöglicht UCB weitere Investitionen in künftige Wachstumstreiber
    Halbjahresbericht 2019: Starkes Ergebnis ermöglicht UCB weitere Investitionen in künftige Wachstumstreiber PR Newswire
    25.07.19 - PR Newswire
    UCB Half Year Report 2019: UCB's Strong Performance Enables Continued Investment Into Future Growth Drivers
    UCB Half Year Report 2019: UCB's Strong Performance Enables Continued Investment Into Future Growth Drivers PR Newswire
    25.07.19 - PR Newswire
    UCB Half Year Report 2019: UCB's Strong Performance Enables Continued Investment Into Future Growth Drivers
    UCB Half Year Report 2019: UCB's Strong Performance Enables Continued Investment Into Future Growth Drivers PR Newswire
    22.03.19 - GlobeNewswire
    UCB SA/NV: Convening Notice to attend the general meeting of shareholders to be held at Bluepoint Brussels
    *** Unofficial English translation – For convenience purposes only ***
    21.01.19 - Finanztrends
    UCB Aktie 2019
    Was sich bei der Aktie von USB in den letzten Jahren abspielt, ist der ganz normale Wahnsinn. Das Papier bewegte sich in den letzten Jahren munter zwischen 50 Euro und 85 ...
    14.08.18 - dpa-AFX
    Evotec verspricht sich Geld aus Haplogen-Kooperation mit Bayer
    Dem Hamburger Biotech-​Unternehmen Evotec winken aus einem neuen Forschungsbündnis mit dem Bayer-​Konzern Umsatz- und Meilenstein-​Zahlungen. Evotecs ...
    < Zurück < Zurück
    von 16
    Weiter > Weiter >

    Newssuche

      

    Videos

      
    09.04.21
    Most Actives - die meistgehandelten Aktien des Tages: Deutsche Telekom, TUI und Daimler
    Viola Grebe blickt auf die meistgehandelten Werte beim Onlinebroker Flatex. Welche Aktien werden aktuell ... Mehr »